Sort
23,748 grants matching “melanoma”
Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy
$211,477Naoto Hirano · University Health Network · R01 · FY2012 · CA
Administration, Evaluation, and Planning
$211,467Elizabeth A Grimm · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Immunotherapy for gliomas with monoclonal antibodies targeting MCSP
$211,426Robert A Fenstermaker · Roswell Park Cancer Institute Corp · R21 · FY2006 · NS
New Cancer Therapeutic Target
$211,410Michael J Spinella · Dartmouth College · R21 · FY2015 · CA
Immunological manipulation of resistance to molecularly targeted inhibitors
$211,410Mary J Turk · Dartmouth College · R21 · FY2017 · CA
Anti-PV1 Therapy for Pancreatic Cancer
$211,410Radu Virgil Stan · Dartmouth College · R21 · FY2013 · CA
Microbiota and the anti-tumor action of anti-CD47 immunomodulation.
$211,410Ralph R Weichselbaum · University Of Chicago · R21 · FY2020 · CA
Abrogation of Therapeutic Escape Pathways in BRAF Mutant Melanoma
$211,354Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2015 · CA
Protein-Protein Interactions in Melanosome Biogenesis
$211,345Vijayasaradhi Setaluri · University Of Wisconsin-Madison · R01 · FY2006 · AR
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells
$211,324Germana Rappa · Nevada Cancer Institute · R01 · FY2009 · CA
Understanding and Overcoming Immunotherapy Resistance in Pediatric High-Grade Glioma
$211,250Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · NS
Characterization of Cancer Transcriptomes using Next Generation Sequencing
$211,158Christopher A Maher · Washington University · R00 · FY2013 · CA
A zebrafish model for studying orbital development and disease
$211,102Alon Kahana · University Of Michigan At Ann Arbor · K08 · FY2011 · EY
Receptor Crosstalk in HNSCC Metastatic Progression
$211,095Steven A. Rosenzweig · Medical University Of South Carolina · R01 · FY2013 · CA
Plasmalemma vesicle-associated protein (PV-1) as a novel target in cancer immunot
$211,084Radu Virgil Stan · Dartmouth College · R21 · FY2013 · CA
Novel oncolytic virotherapy for brain tumors
$210,845Hiroaki Wakimoto · Massachusetts General Hospital · R21 · FY2017 · NS
Hand-Held Infrared Scanner for Early Detection of Melanoma
$210,792Cila Herman · Johns Hopkins University · R01 · FY2011 · CA
Elucidating the Contextual Roles of IL-10 in Patient Response to Cancer Immunotherapy
$210,783David Michael Woods · University Of Colorado Denver · R00 · FY2021 · CA
Antiangiogenic and antitumoral therapy delivered by a dual-expression L. monocyto
$210,739Anu Wallecha · Advaxis, Inc. · R43 · FY2009 · CA
DC Th Crosstalk in CTL Response to Mart 1
$210,613University Of Connecticut Sch Of Med/Dnt · R01 · FY2003 · CA
DC Th Crosstalk in CTL Response to Mart 1
$210,613University Of Connecticut Sch Of Med/Dnt · R01 · FY2004 · CA
Novel Strategies to Broaden the Impact of HIFU Therapy in Cancer Management
$210,600Pei Zhong · Duke University · R21 · FY2008 · CA
Role of Wnt Signaling in melanoma metastasis and melanocyte differentiation
$210,529Ashani Weeraratna · National Institute On Aging · ZIA · FY2010 · AG
Using gene expression profiles to elucidate mechanisms of melanoma progression
$210,529Ashani Weeraratna · National Institute On Aging · ZIA · FY2010 · AG
Endothelial cell injury by cytolytic lymphocytes
$210,527University Of South Carolina At Columbia · R01 · FY2005 · HL